Portal de Periódicos da CAPES

New 2,6,9-trisubstituted adenines as adenosine receptor antagonists: a preliminary SAR profile

2007; Springer Science+Business Media; Volume: 3; Issue: 4 Linguagem: Inglês

10.1007/s11302-007-9068-9

1573-9546

Catia Lambertucci, Gloria Cristalli, Diego Dal Ben, Dhuldeo D. Kachare, Chiara Bolcato, Karl‐Norbert Klotz, Giampiero Spalluto, Rosaria Volpini,

Receptor Mechanisms and Signaling

A new series of 2,6,9-trisubstituted adenines (5–14) have been prepared and evaluated in radioligand binding studies for their affinity at the human A1, A2A and A3 adenosine receptors and in adenylyl cyclase experiments for their potency at the human A2B subtype. From this preliminary study the conclusion can be drawn that introduction of bulky chains at the N 6 position of 9-propyladenine significantly increased binding affinity at the human A1 and A3 adenosine receptors, while the presence of a chlorine atom at the 2 position resulted in a not univocal effect, depending on the receptor subtype and/or on the substituent present in the N 6 position. However, in all cases, the presence in the 2 position of a chlorine atom favoured the interaction with the A2A subtype. These results demonstrated that, although the synthesized compounds were found to be quite inactive at the human A2B subtype, adenine is a useful template for further development of simplified adenosine receptor antagonists with distinct receptor selectivity profiles.